65,437 trials
Type 2 Diabetes Mellitus
Primary: Percentage of Participants With at Least One Symptomatic Hypoglycemic Event — 3.8; 7.3 percentage of participants — p=0.028
Lumbosacral Radiculopathy
Primary: Numerical Rating Leg Pain Score — 2.54; 3.56; 3.78 units on a scale
Refractive Error
Primary: Mean Change From Baseline (Day 0) in Average Corneal Staining Area at Day 30 — -5.04 Percentage of corneal staining
Tracheal Intubation Morbidity
Primary: Success in Learning to Use a Videolaryngoscope(VLS) — 37.5; 62.5; 25; 0 percent of anesthesiologists — p=>0.05
Healthy
Primary: Percent Mean Change From Baseline of International Normalized Ratio (INR) — 0.0452; 0.1605 percent change
Restless Legs Syndrome
Primary: Wake After Sleep Onset (WASO) — 51.50; 78.42; 78.60 minutes — p=<0.0001
Anterior Uveitis · Uveitis
Primary: Change in Excess Central Macular Thickening in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline — -38.60 µm
Acute Respiratory Infection
Primary: Percent of Inhaled Radioactive Tracer Particles Cleared From Lungs — 21.4; 23.1 Percentage of inhaled radioactive tracer
Blood Volume, Extravasation
Primary: Blood Volume — 4.61 Litre
Surgical Wound Dehiscence
Primary: Difference in Time to Closure Between Wounds Surgically Excised With VERSAJET™ Hydrosurgery System and Those Surgically Excised Using Conventional Operating Room…
Schizophrenia
Primary: The Mean Modal Prescribed Daily Dose of Paliperidone Extended Release (ER) From Day 1 to Day 84 — 6.9 mg
Atherosclerosis · Cardiovascular Diseases · Hypercholesterolemia
Primary: Number of Participants With at Least One Non-vertebral Fracture — 198; 189 participants — p=0.678
Lymphoma, Non-Hodgkin
Primary: Number of Participants (Par.) With Confirmed Response as Assessed by the Investigator — 21; 8 participants
Psoriasis
Primary: The Number of Patients Who Achieved at Least a 75% Improvement in PASI (Psoriasis Area and Severity Index) at Week 12 — 3; 41 Participants — p=<0.001
HIV-1
Primary: Percentage of Participants With Viral Load of Less Than 400 Copies/Milliliter [Copies/mL] and Less Than 50 Copies/mL of Human Immunodeficiency Virus (HIV)-1 Ribonucleic…